AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
The Hindu -

AstraZeneca's COVID-19 vaccine may cause rare blood clotting syndrome, but doctors in India are well aware of the risk.

Related Articles

Latest in News

More from The Hindu | AstraZeneca’s COVID-19 vaccine blood clotting syndrome AstraZeneca covid-19 vaccine Thrombosis with Thrombocytopenia Syndrome Vaccine Serum Institute Of India